Cevimeline and Promethazine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cevimeline (cevimeline hydrochloride) and Promethazine (promethazine hydrochloride). Common drug interactions include arthralgia among females and dermatitis atopic among males.
The phase IV clinical study analyzes what interactions people have when they take Cevimeline and Promethazine. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is Cevimeline?
Cevimeline has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 1,480 Cevimeline users. Check the latest studies of Cevimeline.
What is Promethazine?
Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.
37 people who take Cevimeline and Promethazine together, and have interactions are studied.

What are the common drug interactions of Cevimeline and Promethazine, by gender? *:
female:
- Arthralgia (joint pain)
- Confusional state
- Drug ineffective
- Fall
- Malaise (a feeling of general discomfort or uneasiness)
- Weight decreased
- Fluid overload (too much fluid in the blood)
- Hypoxia (low oxygen in tissues)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Overdose
male:
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Fatigue (feeling of tiredness)
- Sleep disorder
- Drug ineffective
- Injection site reaction
- Rash
What are the common drug interactions of Cevimeline and Promethazine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Skin burning sensation
- Skin exfoliation (removal of the oldest dead skin cells)
- Vulval disorder
40-49:
- Fall
- Chills (felling of cold)
- Fatigue (feeling of tiredness)
- Feeling cold
- Blood pressure increased
- Breast cancer
- Diarrhoea
- Dizziness
- Drug ineffective
- Fibromyalgia (a long-term condition which causes pain all over the body)
50-59:
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Drug ineffective
- Fatigue (feeling of tiredness)
- Sleep disorder
- Injection site reaction
- Fluid overload (too much fluid in the blood)
- Hypoxia (low oxygen in tissues)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Overdose
- Right ventricular failure (right half of the heart fails to work)
60+:
- Wound
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Scab (a hard coating on the skin formed during the wound healing)
- Therapeutic response unexpected
- Weight decreased
- Asthenia (weakness)
- Burning sensation
- Decreased appetite
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 32.43%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 32.43%
- Insomnia (sleeplessness): 7 people, 18.92%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 13.51%
- Migraine (headache): 4 people, 10.81%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 10.81%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.81%
- High Blood Pressure: 3 people, 8.11%
- Dry Mouth: 3 people, 8.11%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.41%
* Approximation only. Some reports may have incomplete information.
Do you take Cevimeline and Promethazine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cevimeline (1,480 reports)
- Promethazine (32,300 reports)
Browse all drug interactions of Cevimeline and Promethazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cevimeline:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Promethazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cevimeline and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Promethazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on cevimeline hydrochloride and promethazine hydrochloride (the active ingredients of Cevimeline and Promethazine, respectively), and Cevimeline and Promethazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Flovent and Mucinex D - now
- Could Tamiflu cause Lip Erosion? - 3 seconds ago
- Could Enoxaparin Sodium cause Spinal Osteoarthritis? - 9 seconds ago
- Could Clozaril cause Foetal Exposure During Pregnancy? - 12 seconds ago
- Drug interactions of Moxifloxacin and Zolpidem Tartrate - 15 seconds ago
- Could Acetylcysteine cause Renal Injury? - 18 seconds ago
- Drug interactions of Tylenol W/ Codeine No. 3 and Cimetidine - 21 seconds ago
- Drug interactions of Imatinib Mesylate and Celecoxib - 24 seconds ago
- Could Ibu cause Orchitis? - 37 seconds ago
- Minocycline Hydrochloride vs. Zorvolex, side effect and effectiveness comparison - 44 seconds ago